PubMed

Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.

von Mehren M, Balcerzak SP, Kraft AS, Edmonson JH, Okuno SH, Davey M, McLaughlin S, Beard MT, Rogatko A.

Sarcoma. 2004;8(4):107-11.PMID: 18521404 [PubMed - in process]Related articlesFree article

A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors.

Bekaii-Saab TS, Liu J, Chan KK, Balcerzak SP, Ivy PS, Grever MR, Kraut EH.

Clin Cancer Res. 2008 Jun 1;14(11):3434-40.PMID: 18519774 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).

Petersdorf SH, Rankin C, Head DR, Terebelo HR, Willman CL, Balcerzak SP, Karnad AB, Dakhil SR, Appelbaum FR.

Am J Hematol. 2007 Dec;82(12):1056-62.PMID: 17696203 [PubMed - indexed for MEDLINE]Related articles

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.

Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Williamson S, Gaynor ER, Balcerzak SP, Macdonald JS.

Invest New Drugs. 2004 Nov;22(4):467-73.PMID: 15292717 [PubMed - indexed for MEDLINE]Related articles

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.

Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Goodwin JW, Balcerzak SP, Samlowski WE, Lenz HJ, Macdonald JS.

Invest New Drugs. 2004 Aug;22(3):335-41.PMID: 15122082 [PubMed - indexed for MEDLINE]Related articles

A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S; Southwest Oncology Group Randomized Phase II Study.

Breast Cancer Res Treat. 2004 May;85(2):143-50.PMID: 15111772 [PubMed - indexed for MEDLINE]Related articles

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI.

J Clin Oncol. 2003 Sep 15;21(18):3512-9.PMID: 12972528 [PubMed - indexed for MEDLINE]Related articles

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.

Cancer. 2003 Jul 15;98(2):331-6.PMID: 12872353 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

Velasquez WS, Lew D, Grogan TM, Spiridonidis CH, Balcerzak SP, Dakhil SR, Miller TP, Lanier KS, Chapman RA, Fisher RI; Southwest Oncology Group.

J Clin Oncol. 2003 May 15;21(10):1996-2003.PMID: 12743154 [PubMed - indexed for MEDLINE]Related articles

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, Luthardt FW, Norwood TH, Chen IM, Balcerzak SP, Johnson DB, Appelbaum FR.

Blood. 2002 Dec 1;100(12):3869-76. Epub 2002 Aug 1.PMID: 12393614 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

Marcucci G, Byrd JC, Dai G, Klisovic MI, Kourlas PJ, Young DC, Cataland SR, Fisher DB, Lucas D, Chan KK, Porcu P, Lin ZP, Farag SF, Frankel SR, Zwiebel JA, Kraut EH, Balcerzak SP, Bloomfield CD, Grever MR, Caligiuri MA.

Blood. 2003 Jan 15;101(2):425-32. Epub 2002 Aug 22.PMID: 12393493 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.

Thomas JP, Moore T, Kraut EH, Balcerzak SP, Galloway S, Vandre DD; Ohio State University Phase II Research Consortium Study.

Cancer Invest. 2002;20(2):192-8.PMID: 11901539 [PubMed - indexed for MEDLINE]Related articles

A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.

Kraut EH, Balcerzak SP, Young D, Davis MP, Jacobs SA; Ohio State University Phase II Reseeearch Consortium Study.

Cancer Invest. 2002;20(2):174-9.PMID: 11901536 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Sandor V, Bakke S, Robey RW, Kang MH, Blagosklonny MV, Bender J, Brooks R, Piekarz RL, Tucker E, Figg WD, Chan KK, Goldspiel B, Fojo AT, Balcerzak SP, Bates SE.

Clin Cancer Res. 2002 Mar;8(3):718-28.PMID: 11895901 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.

Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR.

Leukemia. 2001 Feb;15(2):208-16.PMID: 11236936 [PubMed - indexed for MEDLINE]Related articles

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.

Gaynor ER, Unger JM, Miller TP, Grogan TM, White LA Jr, Mills GM, Balcerzak SP, Varterasian M, LeBlanc M, Fisher RI.

J Clin Oncol. 2001 Feb 1;19(3):750-5.PMID: 11157027 [PubMed - indexed for MEDLINE]Related articles

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB.

J Urol. 2001 Jan;165(1):56-60; discussion 60-1.PMID: 11125363 [PubMed - indexed for MEDLINE]Related articles

Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.

Fisher RI, Dana BW, LeBlanc M, Kjeldsberg C, Forman JD, Unger JM, Balcerzak SP, Gaynor ER, Roy V, Miller T.

J Clin Oncol. 2000 May;18(10):2010-6.PMID: 10811664 [PubMed - indexed for MEDLINE]Related articles

A phase II study of 9-aminocamptothecin in patients with refractory breast cancer.

Kraut EH, Balcerzak SP, Young D, O'Rourke MA, Petrus JJ, Kuebler JP, Mayernik DG.

Cancer Invest. 2000;18(1):28-31.PMID: 10701364 [PubMed - indexed for MEDLINE]Related articles

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson SK, Lew D, Miller GJ, Balcerzak SP, Baker LH, Crawford ED.

Cancer. 2000 Mar 1;88(5):1159-65.PMID: 10699907 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study.

Grunberg SM, Crowley J, Hande KR, Giroux D, Munshi N, Lau DH, Schroder LE, Zangmeister MH, Balcerzak SP, Hynes HE, Gandara DR.

Cancer Chemother Pharmacol. 1999;44(6):461-8.PMID: 10550566 [PubMed - indexed for MEDLINE]Related articles

Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.

Kish JA, Benedetti JK, Balcerzak SP, Veith RW, Davis R, Pollock TW, Schuller DE, Ensley JF.

Cancer J Sci Am. 1999 Sep-Oct;5(5):307-11.PMID: 10526672 [PubMed - indexed for MEDLINE]Related articles

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.

Hesketh PJ, Crowley JJ, Burris HA 3rd, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF Jr, Livingston RB, Gandara DR.

Cancer J Sci Am. 1999 Jul-Aug;5(4):237-41.PMID: 10439170 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).

Meyers FJ, Lew D, Lara PN Jr, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED.

Invest New Drugs. 1998-1999;16(4):347-51.PMID: 10426670 [PubMed - indexed for MEDLINE]Related articles

A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.

Sondak VK, Liu PY, Flaherty LE, Fletcher WS, Periman P, Gandara DR, Taylor SA, Balcerzak SP, Meyskens FL Jr.

Cancer J Sci Am. 1999 Jan-Feb;5(1):41-7.PMID: 10188060 [PubMed - indexed for MEDLINE]Related articles

Differential diagnosis of hereditary hemochromatosis from other liver disorders by genetic analysis: gene mutation analysis of patients previously diagnosed with hemochromatosis by liver biopsy.

Bartolo C, McAndrew PE, Sosolik RC, Cawley KA, Balcerzak SP, Brandt JT, Prior TW.

Arch Pathol Lab Med. 1998 Jul;122(7):633-7.PMID: 9674544 [PubMed - indexed for MEDLINE]Related articles

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Spiridonidis CH, Baker LH, Albain KS, Kelly K, Taylor SA, Gandara DR, Livingston RB.

J Clin Oncol. 1998 Jul;16(7):2459-65.PMID: 9667264 [PubMed - indexed for MEDLINE]Related articles

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

Godwin JE, Kopecky KJ, Head DR, Willman CL, Leith CP, Hynes HE, Balcerzak SP, Appelbaum FR.

Blood. 1998 May 15;91(10):3607-15.PMID: 9572995 [PubMed - indexed for MEDLINE]Related articlesFree article

A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.

Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB, Clamon GH, Baker LH.

Cancer. 1998 Apr 1;82(7):1288-95.PMID: 9529020 [PubMed - indexed for MEDLINE]Related articlesFree article

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.

Salmon SE, Crowley JJ, Balcerzak SP, Roach RW, Taylor SA, Rivkin SE, Samlowski W.

J Clin Oncol. 1998 Mar;16(3):890-6.PMID: 9508170 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.

Press OW, LeBlanc M, O'Rourke TJ, Gagnet S, Chapman RA, Balcerzak SP, Fisher RI.

J Clin Oncol. 1998 Feb;16(2):574-8.PMID: 9469343 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of topotecan in advanced gastric cancer: a Southwest Oncology Group study.

Benedetti JK, Burris HA 3rd, Balcerzak SP, Macdonald JS.

Invest New Drugs. 1997;15(3):261-4.PMID: 9387050 [PubMed - indexed for MEDLINE]Related articles

A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma.

Keohan ML, Grever MR, Balcerzak SP, Antman K.

Invest New Drugs. 1997;15(3):255-6.PMID: 9387048 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of topotecan in malignant melanoma.

Kraut EH, Walker MJ, Staubus A, Gochnour D, Balcerzak SP.

Cancer Invest. 1997;15(4):318-20.PMID: 9246152 [PubMed - indexed for MEDLINE]Related articles

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.

Weick JK, Kopecky KJ, Appelbaum FR, Head DR, Kingsbury LL, Balcerzak SP, Bickers JN, Hynes HE, Welborn JL, Simon SR, Grever M.

Blood. 1996 Oct 15;88(8):2841-51.PMID: 8874180 [PubMed - indexed for MEDLINE]Related articlesFree article

Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.

Triozzi PL, Tucker F, Benzies T, Balcerzak SP.

Bone Marrow Transplant. 1996 Jul;18(1):47-52.PMID: 8831995 [PubMed - indexed for MEDLINE]Related articles

GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group study.

Hicks LG, Balcerzak SP, Zalupski M.

Cancer Invest. 1996;14(6):507-12.PMID: 8951354 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study.

Balcerzak SP, Benedetti J, Weiss GR, Natale RB.

Cancer. 1995 Dec 1;76(11):2248-52.PMID: 8635028 [PubMed - indexed for MEDLINE]Related articles

Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial.

Meyskens FL Jr, Kopecky KJ, Appelbaum FR, Balcerzak SP, Samlowski W, Hynes H.

Leuk Res. 1995 Sep;19(9):605-12.PMID: 7564470 [PubMed - indexed for MEDLINE]Related articles

Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.

Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR.

Leukemia. 1995 Jul;9(7):1126-9.PMID: 7630183 [PubMed - indexed for MEDLINE]Related articles

A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group study.

Hewlett J, Kopecky KJ, Head D, Eyre HJ, Elias L, Kingsbury L, Balcerzak SP, Dabich L, Hynes H, Bickers JN, et al.

Leukemia. 1995 Apr;9(4):562-9.PMID: 7723385 [PubMed - indexed for MEDLINE]Related articles

Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.

Marshall ME, Wolf M, Crawford ED, Thompson IM, Flanigan R, Balcerzak SP, Meyers FJ.

Cancer Biother. 1995 Fall;10(3):205-9.PMID: 8547959 [PubMed - indexed for MEDLINE]Related articles

Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.

Meyskens FL Jr, Liu PY, Tuthill RJ, Sondak VK, Fletcher WS, Jewell WR, Samlowski W, Balcerzak SP, Rector DJ, Noyes RD, et al.

J Clin Oncol. 1994 Oct;12(10):2060-5.PMID: 7931474 [PubMed - indexed for MEDLINE]Related articles

Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.

Buys SS, Metch B, Balcerzak SP, Neefe JR, Stuckey WJ.

Cancer Invest. 1994;12(4):399-402.PMID: 8032960 [PubMed - indexed for MEDLINE]Related articles

Treatment of advanced colorectal carcinoma with 5-fluorouracil, leucovorin and Roferon-A: a Southwest Oncology Study Group Study.

Marshall ME, Tangen CM, Berenberg JL, Balcerzak SP, Brown T, Macdonald JS.

Cancer Biother. 1994 Winter;9(4):301-6.PMID: 7719377 [PubMed - indexed for MEDLINE]Related articles

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.

Grever MR, Benedetti J, Balcerzak SP, Taylor SA, Miller TP, Dakhil SR.

Invest New Drugs. 1994;12(3):259-61. No abstract available. PMID: 7534752 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Zalupski MM, Benedetti J, Balcerzak SP, Hutchins LF, Belt RJ, Hantel A, Goodwin JW.

Invest New Drugs. 1993 Nov;11(4):337-41.PMID: 8157477 [PubMed - indexed for MEDLINE]Related articles

Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.

Supko JG, Balcerzak SP, Kraut EH.

Cancer Res. 1993 Oct 15;53(20):4843-9.PMID: 8402671 [PubMed - indexed for MEDLINE]Related articlesFree article

Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Grunberg SM, Crowley J, Livingston R, Gill I, Williamson SK, O'Rourke T, Braun T, Marshall ME, Weick JK, Balcerzak SP, et al.

J Clin Oncol. 1993 Aug;11(8):1598-601.PMID: 8393099 [PubMed - indexed for MEDLINE]Related articles

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL, et al.

J Clin Oncol. 1993 Jul;11(7):1276-85.PMID: 8315425 [PubMed - indexed for MEDLINE]Related articles